Variants in DAT1 have been associated with attention deficit hyperactivity disorder (ADHD) (62), Tourette’s Syndrome (63), childhood Parkinsonism–dystonia (64), substance abuse (65), and eating disorders (66). This evidence concerns the gene SLC6A3 and attention deficit-hyperactivity disorder.